French firm's drug succeeds in pivotal trial for progressive MS

LONDON, April 17 (Reuters) - An experimental drug comprising of a high-dose formulation of the food additive biotin has successfully helped patients with progressive multiple sclerosis in a major...

from Reuters: Mergers News http://ift.tt/1PWF9rs